# id: 169232
# generation: 73
# extra edges: []
# score: 128.0 / 128.0
# following constraints: True
# complexity: 40

targets,	factors
AKT,	PDK1 | mTOR
EGF,	EGF
ERBB1,	EGF & !erlotinib & !pertuzumab
ERBB2,	ERBB2 & !erlotinib & !pertuzumab
ERBB3,	ERBB3 & !erlotinib & !pertuzumab | HRG & !erlotinib & !pertuzumab
ERK1_2,	ERBB3 | MEK1_2 | PDK1
HRG,	HRG
MEK1_2,	ERBB1 | ERBB2 | ERBB3 | MEK1_2
PDK1,	ERBB1 | ERBB2 | ERBB3 | PDK1
PKCa,	PLCg | PKCa
PLCg,	ERBB1 | ERBB2 | ERBB3 | PLCg
erlotinib,	erlotinib
mTOR,	mTOR | AKT
p70S6K,	ERK1_2 | p70S6K
pertuzumab,	pertuzumab
trastuzumab,	trastuzumab
